Wandercraft’s Self-Balancing Exoskeleton Eve for People With Spinal Cord Injuries Gets FDA Authorization

Wandercraft announced that it had received U.S. Food and Drug Administration (FDA) authorization for Eve, a self-balancing personal exoskeleton designed for wheelchair users with spinal cord injuries. Clinical trials confirmed its safety and usefulness, and it is expected to launch in the U.S. within a few months.

For wheelchair users with spinal cord injuries, an important feature of Eve is that it is authorized to assist with standing and walking without external support such as handrails or crutches. It is intended for users with a wide range of spinal cord injury severities. Wandercraft says clinical trials demonstrated its safety and ease of use, providing a concrete indication of the conditions under which a personal exoskeleton for everyday use can be made available in the U.S.